A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy.
Vita GL, Sframeli M, Licata N, Bitto A, Romeo S, Frisone F, Ciranni A, Pallio G, Mannino F, Aguennouz M, Rodolico C, Squadrito F, Toscano A, Messina S, Vita G.
Vita GL, et al. Among authors: messina s.
Brain Sci. 2021 Jan 16;11(1):115. doi: 10.3390/brainsci11010115.
Brain Sci. 2021.
PMID: 33467104
Free PMC article.